Manufacturers of drug products from outside the European Union and Mutual Recognition Agreement (MRA) countries are required to submit their product to batch re-testing for release in the EU. Current MRA countries include Australia, New Zealand, Switzerland, Israel, Japan, the United States, and Canada. All other countries are subject to the batch re-test release requirement with certification by a Qualified Person (QP).

​

The J. Molner team, with our EU GMP-certified laboratory and QP are capable of ensuring that your products are released into the market in a safe and timely manner. This service includes:

​

• Batch testing and release for approved medical products according to GMP requirements

• QP-certified batch release analysis

• One-time and ongoing audits of manufacturing facilities to ensure compliance with GMP

• Assuming the responsibility as a QP for your product

 

Take a look inside our GMP laboratory with our virtual tour here!

 

Review the comments to EU GMP Annex 16 from the Estonian State Agency of Medicines here.=

​

Contact us today to explore how we can help you get to market faster!

​

 

​